LTR Pharma Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	25.78	31.81	3.1	1.73	1.91	0.15
Cash & Short-Term Investments	25.78	31.81	3.1	1.73	1.91	0.15
Cash Growth	-24.33%	925.31%	79.46%	-9.56%	1205.48%	-
Accounts Receivable	0.01	0	-	-	-	-
Other Receivables	0.16	0.24	0.27	0.06	0.04	-
Receivables	0.18	0.25	0.27	0.06	0.04	-
Inventory	0.02	0.02	-	-	-	-
Total Current Assets	26.31	32.07	3.37	1.79	1.95	0.15
Property, Plant & Equipment	0.01	0.01	0	-	-	-
Long-Term Investments	1	0.12	-	-	-	-
Other Long-Term Assets	-	-	-	-	-	0
Total Assets	27.32	32.21	3.37	2.09	2.25	0.42
Accounts Payable	0.12	0.11	0.24	0.01	0.47	0
Accrued Expenses	0.21	0.5	0.13	0.01	0.01	0
Short-Term Debt	-	-	-	-	-	0.36
Other Current Liabilities	0.13	0.1	0.06	-	-	0.1
Total Current Liabilities	0.46	0.7	0.43	0.02	0.48	0.46
Total Liabilities	0.46	0.7	0.43	0.02	0.48	0.46
Common Stock	44.11	44.11	10.74	4.53	2.79	-
Retained Earnings	-20.83	-15.07	-9.48	-2.52	-1.07	-0.04
Comprehensive Income & Other	3.58	2.47	1.67	0.07	0.04	-
Shareholders' Equity	26.86	31.51	2.94	2.07	1.77	-0.04
Total Liabilities & Equity	27.32	32.21	3.37	2.09	2.25	0.42
Total Debt	-	-	-	-	-	0.36
Net Cash (Debt)	25.78	31.81	3.1	1.73	1.91	-0.21
Net Cash Growth	-24.33%	925.31%	79.46%	-9.56%	-	-
Net Cash Per Share	0.14	0.19	0.02	0.01	-	-
Filing Date Shares Outstanding	181.65	180.98	153.8	414.9	-	-
Total Common Shares Outstanding	181.65	180.98	139.42	414.9	-	-
Working Capital	25.85	31.37	2.94	1.77	1.48	-0.32
Book Value Per Share	0.15	0.17	0.02	0.00	-	-
Tangible Book Value	26.86	31.51	2.94	2.07	1.77	-0.04
Tangible Book Value Per Share	0.15	0.17	0.02	0.00	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.